About Emboline
Emboline is a company based in Santa Cruz (United States) founded in 2011. Emboline has raised $101.92 million across 5 funding rounds from investors including GAM Investments, ShangBay Capital and SV Tech Ventures. The company has 16 employees as of December 31, 2024. Emboline offers products and services including Emboliner Catheter. Emboline operates in a competitive market with competitors including Claret Medical, Protembis, Synaptive Medical, Filterlex Medical and Keystone Heart, among others.
- Headquarter Santa Cruz, United States
- Employees 16 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Emboline Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$101.92 M (USD)
in 5 rounds
-
Latest Funding Round
$20 M (USD), Series C
Mar 11, 2026
-
Investors
GAM Investments
& 4 more
-
Employee Count
16
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Emboline
Emboline offers a comprehensive portfolio of products and services, including Emboliner Catheter.
Catheter that captures emboli during TAVR to prevent brain lesions
People of Emboline
Unlock access to complete
Funding Insights of Emboline
Emboline has successfully raised a total of $101.92M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in March 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Emboline
Emboline has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include GAM Investments, ShangBay Capital and SV Tech Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Life sciences and tech focused VC firm funding companies in the US and Israel
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Emboline
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Emboline
Investment portfolio details for Emboline
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Emboline
Detailed financials for Emboline
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Emboline Comparisons
Peer comparison for Emboline
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Emboline
Emboline operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Claret Medical, Protembis, Synaptive Medical, Filterlex Medical and Keystone Heart, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cerebral vascular protection systems for endovascular procedures are developed.
|
|
| Locked | Locked | Locked |
Manufacturer of cerebral protection device
|
|
| Locked | Locked | Locked |
Planning and imaging solutions for neurosurgery are developed.
|
|
| Locked | Locked | Locked |
Developer of an embolic protection device
|
|
| Locked | Locked | Locked |
Embolic cerebral protection devices
|
Detailed competitors of Emboline
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Emboline
Complete news archive for Emboline
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emboline
Emboline was founded in 2011 and raised its 1st funding round 7 years after it was founded.
Emboline is headquartered in Santa Cruz, United States. It is registered at Santa Cruz, California, United States.
Emboline is a funded company, having raised a total of $101.92M across 5 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Emboline is 16.
Emboline was founded in 2011 in Santa Cruz, United States, within the medical device sector. An aortic embolic protection device known as the Emboliner is developed to prevent embolic events, such as strokes, during catheter-based heart valve replacements. The device features a mesh filter deployed in the aorta, allowing procedures to proceed under protection. Operations focus on interventional cardiology applications across the United States.
Emboline's top competitors include Protembis, Synaptive Medical and Claret Medical.
Emboline offers Emboliner Catheter.
Emboline has 5 investors. Key investors include GAM Investments, ShangBay Capital, SV Tech Ventures, Matrix Capital Management, and Trinity Capital.